CCC
GSK icon

Chesapeake Capital Corp’s GSK GSK Stock Holding History

Chesapeake Capital Corp’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$700K Buy
13,352
+450
+3% +$23.8K 0.37% 88
2026
Q1 		$712K Hold
12,902
– – 0.51% 75
2025
Q4 		$633K Buy
12,902
+6,371
+98% +$297K 0.53% 80
2025
Q3 		$282K Buy
+6,531
New +$255K 0.25% 136

Other funds holding GSK

JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

Chesapeake Capital Corp's GSK Position: Q2 2026 in Review

Chesapeake Capital Corp increased its GSK (GSK) stake by 3.5% in Q2 2026, buying an estimated $23.8K and bringing the position to 13,352 shares worth $700K. The position accounts for 0.37% of the portfolio, ranked #88.

Chesapeake Capital Corp first reported a position in GSK in Q3 2025 and has held it in 4 quarters since. The position peaked at $712K in Q1 2026. 439 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Chesapeake Capital Corp held 13,352 shares of GSK worth $700K as of Q2 2026.
  • Chesapeake Capital Corp bought 450 GSK shares in Q2 2026, an estimated $23.8K.
  • GSK made up 0.37% of Chesapeake Capital Corp's portfolio in Q2 2026, its #88 holding.
  • Chesapeake Capital Corp first reported a position in GSK in Q3 2025 and has held it in 4 quarters since.
  • Chesapeake Capital Corp's GSK position peaked at $712K in Q1 2026.
  • 439 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Chesapeake Capital Corp's 13F filing for Q2 2026, filed 29 Jul 2026.